The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of isolated peritoneal versus other metastatic sites in colorectal cancer (CRC) patients treated by systemic chemotherapy: Findings from 9,265 pts in the ARCAD database.
 
Jan Franko
No Relationships to Disclose
 
Qian Shi
No Relationships to Disclose
 
Jeffrey P. Meyers
No Relationships to Disclose
 
Volker Heinemann
Honoraria - Amgen; Merck; Roche; Sanofi
Consulting or Advisory Role - Amgen; Merck; Roche; Sanofi
Research Funding - Amgen; Merck; Roche; Sanofi
Travel, Accommodations, Expenses - Merck; Roche
 
Alfredo Falcone
No Relationships to Disclose
 
Niall C. Tebbutt
No Relationships to Disclose
 
Tim Maughan
No Relationships to Disclose
 
Matthew Seymour
No Relationships to Disclose
 
Leonard Saltz
Consulting or Advisory Role - Abbvie; Lilly; McNeil PPC (I); Roche/Genentech
Research Funding - Taiho Pharmaceutical
 
Christophe Tournigand
No Relationships to Disclose
 
Eduardo Diaz-Rubio
No Relationships to Disclose
 
Ioannis Sougklakos
No Relationships to Disclose
 
Benoist Chibaudel
No Relationships to Disclose
 
Joseph Moen
No Relationships to Disclose
 
Aimery De Gramont
No Relationships to Disclose
 
Richard A. Adams
No Relationships to Disclose
 
Daniel J. Sargent
No Relationships to Disclose
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche